Nanoplatform‐Enabled Genetic Interventions for Central Nervous System Disorders: Advances in Delivery Strategies and Therapeutic Potential
Abstract Central nervous system (CNS) disorders are driven by complex genetic and epigenetic factors. While gene‐based interventions (siRNA, mRNA, CRISPR systems, etc.) hold transformative potential, their clinical application is severely constrained by inefficient delivery, especially across the bl...
Saved in:
| Main Authors: | Fuming Liang, Shizhen Cui, Jing Yang, Zhaohui He, Ling Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Advanced Genetics |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ggn2.202500010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zein-Based Nanocarriers: Advances in Oral Drug Delivery
by: Yuxin Liu, et al.
Published: (2025-07-01) -
Intranasal Drug Delivery Technology in the Treatment of Central Nervous System Diseases: Challenges, Advances, and Future Research Directions
by: Xunxun Wu, et al.
Published: (2025-06-01) -
Progressive microneedles for targeting and intelligent drug delivery
by: Jiaqi Li, et al.
Published: (2025-06-01) -
Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers
by: Radka Boyuklieva, et al.
Published: (2025-06-01) -
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
by: Wu H, et al.
Published: (2025-05-01)